Erik Nord

5.8k total citations
87 papers, 4.0k citations indexed

About

Erik Nord is a scholar working on Economics and Econometrics, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Erik Nord has authored 87 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Economics and Econometrics, 51 papers in General Health Professions and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Erik Nord's work include Health Systems, Economic Evaluations, Quality of Life (66 papers), Healthcare Policy and Management (37 papers) and Global Health Care Issues (25 papers). Erik Nord is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (66 papers), Healthcare Policy and Management (37 papers) and Global Health Care Issues (25 papers). Erik Nord collaborates with scholars based in Norway, Australia and United States. Erik Nord's co-authors include Jeff Richardson, Trude Arnesen, Paul T. Menzel, José Luis Pinto Prades, Peter A. Ubel, Andrew Street, Helga Kuhse, Rune Johansen, Peter Singer and Norman Daniels and has published in prestigious journals such as Social Science & Medicine, Journal of Clinical Epidemiology and International Journal of Cancer.

In The Last Decade

Erik Nord

84 papers receiving 3.6k citations

Peers

Erik Nord

GHP

PPCH

PHEOH

HEALT

Jan Abel Olsen Norway

Koonal Shah United Kingdom

John A. Nyman United States

James W. Bush United States

Hareth Al‐Janabi United Kingdom

Helen Levy United States

Xander Koolman Netherlands

Bengt Liljas Sweden

Paula Lorgelly United Kingdom

Seth A. Seabury United States

Jan Abel Olsen Norway

Erik Nord

1.8k ×0.6

1.3k ×0.6

GHP

167 ×0.6

PPCH

414 ×1.5

PHEOH

293 ×1.4

HEALT

Citations per year, relative to Erik Nord Erik Nord (= 1×) peers Jan Abel Olsen

Countries citing papers authored by Erik Nord

Since Specialization

Citations

This map shows the geographic impact of Erik Nord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Nord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Nord more than expected).

Fields of papers citing papers by Erik Nord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Nord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Nord. The network helps show where Erik Nord may publish in the future.

Co-authorship network of co-authors of Erik Nord

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Nord. A scholar is included among the top collaborators of Erik Nord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Nord. Erik Nord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schlander, Michael, Silvio Garattini, Søren Holm, et al.. (2015). Interventions For Ultra-Rare Disorders (Urds) And The Logic Of Cost Effectiveness. Value in Health. 18(3). A6–A6. 1 indexed citations

Nord, Erik. (2014). Cost-Value Analysis of Health Interventions: Introduction and Update on Methods and Preference Data. PharmacoEconomics. 33(2). 89–95. 18 indexed citations

Schlander, Michael, Silvio Garattini, Peter L. Kolominsky‐Rabas, et al.. (2013). Incremental Cost Per Quality-adjusted Life Year Gained? The Need for Alternative Methods to Evaluate Medical Interventions for Ultra-rare Disorders. Value in Health. 16(7). A324–A324. 4 indexed citations

Dalgard, Odd Steffen, Kristin S. Mathiesen, Erik Nord, et al.. (2011). Bedre føre var. Psykisk helse: Helsefremmende og forebyggende tiltak og anbefalinger. Duo Research Archive (University of Oslo). 8 indexed citations

Nord, Erik, et al.. (2010). Effects of programs in school for preventing mental problems.. Norsk Epidemiologi. 20(1). 15–22. 1 indexed citations

Drummond, Michael, Diana Brixner, Marthe R. Gold, et al.. (2009). Toward a Consensus on the QALY. Value in Health. 12. S31–S35. 92 indexed citations

Nord, Erik, et al.. (2009). QALYs: is the value of treatment proportional to the size of the health gain?. Health Economics. 19(5). 596–607. 21 indexed citations

Nord, Erik, Norman Daniels, & Mark S. Kamlet. (2009). QALYs: Some Challenges. Value in Health. 12. S10–S15. 133 indexed citations

Nord, Erik. (2004). Concerns for the worse off: fair innings versus severity. Social Science & Medicine. 60(2). 257–263. 81 indexed citations

10.

Schwarzinger, Michaël, Jean‐Louis Lanoë, Erik Nord, & Isabelle Durand‐Zaleski. (2003). Lack of multiplicative transitivity in person trade‐off responses. Health Economics. 13(2). 171–181. 9 indexed citations

11.

Nord, Erik. (2001). The desirability of a condition versus the well being and worth of a person. Health Economics. 10(7). 579–581. 20 indexed citations

12.

Gulbrandsen, Nina, Finn Wislöff, Erik Nord, et al.. (2001). Cost–utility analysis of high‐dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma. European Journal Of Haematology. 66(5). 328–336. 34 indexed citations

13.

Arnesen, Trude & Erik Nord. (2000). The value of DALY life: problems with ethics and validity of disability adjusted life years. Leprosy Review. 71(2). 123–7. 29 indexed citations

14.

Gulbrandsen, Nina, et al.. (1999). Therapeutic Options in the Treatment of Multiple Myeloma. PharmacoEconomics. 16(4). 329–341. 15 indexed citations

15.

Nord, Erik, Andrew Street, Jeff Richardson, Helga Kuhse, & Peter Singer. (1996). The significance of age and duration of effect in social evaluation of health care. Health Care Analysis. 4(2). 103–111. 80 indexed citations

16.

Nord, Erik, Jeff Richardson, Andrew Street, Helga Kuhse, & Peter Singer. (1995). Maximizing health benefits vs egalitarianism: An Australian survey of health issues. Social Science & Medicine. 41(10). 1429–1437. 181 indexed citations

17.

Nord, Erik. (1995). The Person-trade-off Approach to Valuing Health Care Programs. Medical Decision Making. 15(3). 201–208. 186 indexed citations

18.

Nord, Erik, et al.. (1993). Social Evaluation of Health Care Versus Personal Evaluation of Health States:Evidence on the Validity of Four Health-state Scaling Instruments Using Norwegian and Australian Surveys. International Journal of Technology Assessment in Health Care. 9(4). 463–478. 98 indexed citations

19.

Nord, Erik. (1993). The trade-off between severity of illness and treatment effect in cost-value analysis of health care. Health Policy. 24(3). 227–238. 150 indexed citations

20.

Nord, Erik. (1990). Reducing Sick Leave Costs by shortening Waiting Periods for Elective surgery. Medical Decision Making. 10(2). 95–101. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact